Hysteroscopic evaluation of endometrial changes and fallopian tubal functions in women using progestin-only contraceptives

The purpose of this prospective study was to investigate whether office hysteroscopy (OH) can be used to assess the mechanisms of action of progestogen-only contraceptives (POCs), diagnose possible local causes of abnormal uterine bleeding (AUB), and support the treatment plan of symptomatic patients using POCs compared with those who do not use hormones. The study included 140 women who were divided into two groups. Group A consisted of 70 women who used POCs, whereas group B consisted of 70 women who did not use hormones. They were successively examined using transvaginal ultrasonography (TVS), OH, and endometrial sampling. The TVS results were consistent with those of OH and histopathology. The changes in endometrial thickness and vasculature, as well as fallopian tube (FT) functions, were significantly more pronounced in POC users than in non-POC users. There was a significant reduction in the peristalsis of the proximal part of the FT, as well as a reduction in the bubble flow test in group A compared with group B. In addition, the combination of peristalsis and the bubble flow test (Darwishscope test) was significantly lower in group A. It was concluded that using OH as a simple diagnostic tool in women with POCs would contribute to a better understanding of the mechanisms of endometrial and FT effects and explain some local endometrial causes of AUB. This ensures that the combination of TVS and OH would limit routine endometrial sampling in POCs users. Key words: Endometrium, Fallopian tubes, Hysteroscopy, Contraception, Progestins, Ultrasonography Received : November 16, 2023 Revised : January 16, 2024 Accepted : February 9, 2024 Correspondence to Atef Darwish Department of Obstetrics & Gynecology, Woman’s Health University Hospital, Assiut University Faculty of Medicine, Besery Way, Al Walideyah Al Qebleyah, Asyut 2, Assiut 71111, Egypt Tel: 20-0201001572723 Fax: 20-02-088-2368377 E-mail: [email protected] Original Article

An increasing number of progestogen-only contraceptives (POCs) are being used worldwide because they have no estrogen-related side effects or complications, do not inter- fere with breastfeeding, and interest in long-acting reve- rsible contraceptive methods (LARC) is increasing. The possible mechanisms of the contraceptive action of POCs include inhibition of ovulation at varying percentages, alteration of the biophysical properties of cervical mucus, reduction of fallopian tube (FT) ciliary motility and tubal contractile muscle strength, and/or alteration of endometrial receptivity. 1 However, the incidence of unwanted and distres- sing forms of abnormal uterine bleeding (AUB) was sign- Journal of Medicine and Life Science eISSN: 2671-4922 Vol. 21, No. 2, May 2024 22 https://medsci.jejunu.ac.kr/ Journal of Medicine and Life Science ificantly higher with POCs than with other methods. 2-7 There is a need for a better understanding of the mechanisms of AUB in women using POCs, 8 and thus for individualized treatment rather than the current empirical lines of therapy. 9 Office hysteroscopy (OH) has long been used to examine the uterine cavity in many gynecological conditions such as AUB, 10 unexplained infertility, and recurrent pregnancy loss. 11,12 In recent years, we have extensively studied the proximal part of the FT using a bubble flow test and phys - iological peristalsis via OH. 12 In addition, the combination of the bubble flow test and peristalsis (Darwishscope test) proved to be better than either test alone for assessing the function of the proximal part of the FT. 13 This study aimed to assess whether OH can be used to evaluate the mecha - nisms of action of POCs, diagnose possible local causes of AUB, and support in developing a treatment plan for pa - tients experiencing symptoms who use POCs compared to those who do not use hormones.

This prospective cross-sectional study was conducted between August 2021 and July 2023 at the OH unit of the Women’s Health University Hospital of Assiut University, in women of childbearing age who had undergone OH for various indications. This study was approved by the eth - ics committee of the Faculty of Medicine (No. 17101330) and registered on ClinicalTrials.gov (NCT04368104). The sample size was calculated using G*Power 3.1.3 software (Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Ger - many) and amounted to 140 cases, which were divided into two groups according to the use of POCs. Group A included 70 patients who used any method of POCs and complained of AUB with or without abnormal transvaginal ultrasonog - raphy (TVS). Group B comprised women with infertility who underwent OH during the same period but did not use hormones or contraceptives. After preoperative counseling, all patients agreed to provide written consent. A complete medical history was obtained from all patients, including a history of contraceptive use (method, duration, regularity of use, side effects, complications, and any interruptions), a therapeutic history, and a thorough physical examination. Clinically, biochemically, or sonographically diagnosed pre- gnancies, recent stroke or ischemic heart disease, heavy vaginal bleeding, active pelvic inflammatory disease, coag- ulopathies, and severe comorbidities, such as severe hyper- tension and severe cardiac, neurological, or breast disease, were excluded from this study. Women using any form of contraception or hormones were excluded from group B. The vulva, vagina, and thighs were disinfected with a 10% povidone-iodine solution. Subsequently, sterile drapes were applied. OH was performed with a rigid 2.6 mm 30° scope with a 3.2 mm outer sheath (Karl Storz, Tuttlingen, Germa- ny). Initially, a vaginoscopic approach was attempted in all cases; however, if difficulties were encountered, the anterior lip of the cervix was grasped using a multitoothed volsel - lum. The uterus was then distended with normal saline at a pressure of 60-80 mmHg, which was generated by a pneu - matic sphygmomanometer cuff wrapped around a 500 mL 0.9% saline infusion bottle. The endoscope, connected to a 250 W Xenon light source, was carefully inserted through the cervical canal and internal os. To perform a perfect hysteroscopic assessment of the endometrial cavity, the following steps were followed: a clear panoramic view of the uterine cavity was achieved by placing the hysteroscope into the cervical canal and waiting for a while to achieve homogeneous dilation and drainage of blood clots from the cervix. The uterine cavity should be examined systematical- ly, starting with the anterior and posterior fundus and lateral walls. The examination is considered complete when both tubal ostia have been reached, and any gross pathology, such as septum, adhesions, polyp(s), myoma, or any prolif - eration, has been described. Hysteroscopic assessment of the endometrial thickness began with a revision of the TVS report. During TVS, an endometrium (EM) of 8-11 mm was considered normal. For OH, the EM was considered normal if it appeared to be of normal thickness, with moderately developed glandular orifices, and evenly distributed blood vessels in a healthy endometrium. For TVS, a thin EM was assumed if it was ≤7 mm. In OH, a thin EM was assumed Office hysteroscopy in progestin-only contraception 23 https://medsci.jejunu.ac.kr/ Atef Darwish, Ibrahim Mohammad, Samuel Gendy, Dina Darwish, Mohammad Ramdan when narrow glandular openings and thin, poorly distrib - uted blood vessels were observed in the fragile endometri - um. 14 In the TVS, a thick EM was assumed when it meas - ured 12-16 mm (excluding the secretory phase). A thick EM was identified in the OH as diffusely increased thickness with prominent glandular orifices. In TVS, endometrial hy- perplasia is assumed when the EM appears as an echogenic diffuse smooth thickening >10 mm. Hysteroscopically, it is recognized as local or diffuse endometrial thickening with a papillary or polypoid appearance, abnormal vascular pat - terns, glandular cysts, and glandular outlets with abnormal architectural features. 15 In addition to the subjective assessment of endometrial thickness, a simple hysteroscopic endometrial thickness test was performed. The telescope was advanced until the fun - dus was reached and then extracted along the posterior wall up to the cervix with gentle pressure. If a significant furrow (half the circumference of the hysteroscopic sheath) formed along the pathway, the EM was considered thick. If there was no furrows were observed, the EM was mostly thin. If a shallow furrow (one-quarter of the circumference of the hysteroscopic sheath) is formed, it is mostly a normal EM. The endometrial vasculature appeared normal, congested, with petechiae, ecchymosis, and abnormal or suspicious vascular patterns. The endometrial color was pale, pink, reddish, or dark red, as previously described. 10 All cases re- ported bleeding upon touching. The next step in all cases was to assess FT function. Prerequisites for successful access to the FT via hysteroscopy include the utilization of a 300 mm telescope and skillful use of its rotation to reach both cornua (tilting it to the right to see the left side and vice versa). The fundamental anatomic triad (Darwish hysteroscopic triad) was observed (Darwish triad, DT). 16 This is the conical part of the FT (Fig. 1A). Its base is a fine cornual circle (ostium) representing the end of the endometrial cavity. The ostium is followed by a shallow conical groove, which is the converging wall of the first millimeter of the intramural part of the FT. Finally, Figure 1. (A) Darwish hysteroscopic triad. (B) Bubble flow test (a bubble is seen at the ostium). (C) Congested thin endometrium with evident capillaries. (D) Congested thin endometrium in the form of dilated, tortuous, and worm-like capillaries. B D A C Vol. 21, No. 2, May 2024 24 https://medsci.jejunu.ac.kr/ Journal of Medicine and Life Science a distal pinhole dark spot (the narrowest part of the FT) rep- resents the summit of the cone. Considering DT is essential in evaluating tubal patency and physiology during hys - teroscopy. If the DT was clearly accessible, a comment was provided regarding its shape. If there were osteal lesions, such as tiny polyps or fine adhesions, which may hinder the proper evaluation of tubal anatomy and physiology, the hys- teroscopist would report them. The passage of air bubbles in the irrigating fluid towards the DT has been reported. If there was no air bubbles were observed, the hysteroscopist injected 2 mL of air into the rubber end of the sterile in - fusion set. The results of the hysteroscopic bubble suction test were considered positive if air bubbles passed through the DT within 1 minute (Fig. 1B). During this period, nei - ther air injection nor increased pressure was applied. If no passage of gas bubbles occurred, the examiner waited for 1 minute to exclude tubal spasms. If there were no passage of bubbles through the DT and their accumulation at the cor - nual end, the test was considered negative. Simultaneously, careful visualization of any changes in the shape of the os - tium and the intramural part of the FT, particularly during the passage of air bubbles, was recorded in all cases. Tubal peristalsis is defined as the rhythmic opening and closing of the ostium and intramural fallopian tube under constant intrauterine pressure, that is, periodic changes in the DT in the form of widening followed by collapse on meticulous observation. If the ostium and intramural part of the tube were opened, followed by the collapse and non-visualiza - tion of the dark pinhole spot of the DT for a while, positive peristalsis was reported. The same procedure was repeated on the contralateral side. At the end of OH, Novak’s curette biopsies of the most suspicious areas of EM were obtained under hysteroscopic guidance and sent for histopathological examination. The SPSS version 24 (IBM, Armonk, NY, USA) was used to analyze the data. Quantitative data were expressed as mean±standard deviation. Qualitative data were expressed as frequencies and percentages. The independent-sample Table 1. Sociodemographic data of studied patients Characteristic Study group (n=70) Control group (n=70) Test P-value Age (years) 29.81±4.96 31.29±5.53 1.67 † 0.10 Parity 3 (1-5) 2 (0-3) 845 ‡ 0.001* Residence Rural 39 (55.7) 42 (60.0) Urban 31 (44.3) 28 (40.0) 0.264 § 0.608 Education Illiterate 39 (55.7) 35 (50.0) Primary school 18 (25.7) 20 (28.6) Secondary school 10 (14.3) 13 (18.6) High level 3 (4.3) 2 (2.9) 0.913 § 0.822 Occupation Housewife 62 (88.6) 65 (92.9) 0.763 § 0.382 Employee 8 (11.4) 5 (7.1) Infertility Yes 0 (0.0) 62 (88.0) 107.72 § <0.001* No 70 (100.0) 8 (12.0) Values are presented as frequency (%), mean±standard mediation, or median (range). *P-value was significant if <0.05. † Independent t-test. ‡ Mann Whitney U test. § Chi square test. Office hysteroscopy in progestin-only contraception 25 https://medsci.jejunu.ac.kr/ Atef Darwish, Ibrahim Mohammad, Samuel Gendy, Dina Darwish, Mohammad Ramdan t-test and Mann-Whitney U test were used to compare the means of normally and abnormally distributed data, respec- tively. The chi-squared test was used to compare nonpar - ametric data. Probability ( P-value) <0.05 was considered significant, 0.05 was considered non-significant.

This prospective study included 140 patients who under - went OH and were divided into two groups. Group A used POCs, whereas group B included infertile women who did not use any hormones. There were no statistically signif - icant differences between the groups regarding sociode - mographics, apart from parity and infertility, as shown in Table 1. Group A was using POCs in the form of traditional progesterone-only pills (POP) containing levonorgestrel (LNG) 0.03 mg (Microlut; Bayer, Leverkusen, Germany) in 21 cases, desogestrel-containing POP 75 g (Cerazette; MSD, Rahway, NJ, USA) in 11 cases, etonogestrel implants 68 mg (Implanon; MSD) in 16 cases, medroxyprogesterone acetate (MPA) 150 mg (Depo-Provera; Pfizer, New York, NY, USA) in 20 cases, and LNG intrauterine system (IUS) 52 mg (Mirena; Schering AG, Berlin, Germany) in two cas- es. The mean duration of exposure to POCs was 6.56±3.05 months, with a range of 3 to 18 months. Table 2 shows the Table 2. Indications of office hysteroscopy among studied patients Indication of office hysteroscopy Study group (POCs) (n=70) Control group (infertility) (n=70) Chi-square test P-value* Breakthrough bleeding 34 (48.6) 0 (0.0) 118 <0.001 Menorrhagia 18 (25.7) 8 (11.4) Metrorrhagia 11 (15.7) 0 (0.0) Suspected IU lesion by TVS 7 (10.0) 0 (0.0) Unexplained infertility 0 (0.0) 31 (44.3) Pre-ICSI 0 (0.0) 31 (44.3) Values are presented as frequency (%). POC: progestogen-only contraceptive, IU: intrauterine, TVS: transvaginal ultrasonography, ICSI: intracytoplasmic sperm injection. * P-value was significant if <0.05. Table 3. Indications of office hysteroscopy among studied patients Characteristic Study group A Control group B (n=75) Chi-square P-value*Total (n=70) MPA (n=20) Microlut (n=21) Implanon (n=16) Cerazette (n=11) Mirena (n=2) Endometrial thickness Normal 36 (51.4) 5 (25.0) 14 (66.7) 6 (37.5) 9 (81.8) 2 (100.0) 60 (85.7) 19 <0.001 Thin 27 (38.3) 12 (60.0) 7 (33.3) 7 (33.3) 1 (9.1) 0 (0.0) 1 (1.4) 30 <0.001 Polyp 3 (4.3) 2 (10.0) 0 (0.0) 0 (0.0) 1 (9.1) 0 (0.0) 7 (10.0) 1.72 NS Subseptate uterus 3 (4.3) 0 (0.0) 0 (0.0) 3 (18.7) 0 (0.0) 0 (0.0) 1 (1.4) 1.03 NS Endometrial hyperplasia 1 (1.4) 1 (5.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.4) - NS Endometrial vasculature Normal 45 (64.3) 4 (20.0) 17 (81.0) 12 (75.0) 10 (90.9) 2 (100.0) 61 (87.1) 9.95 0.002 Pale 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 5 (7.1) 22.62 <0.001 Congested 25 (34.7) 16 (80.0) 4 (19.0) 4 (25.0) 1 (9.1) 0 (0.0) 4 (5.7) 19 <0.001 Values are presented as frequency (%). MPA: medroxyprogesterone acetate, NS: no significance. * P-value was significant if <0.05. Vol. 21, No. 2, May 2024 26 https://medsci.jejunu.ac.kr/ Journal of Medicine and Life Science indications for OH in both groups. The only significant difference between the two groups was the documentation of viscid cervical mucus in 26 cases (37.1%) in group A out of 32 cases using POP compared to zero cases in group B ( P<0.001). Regarding the endometrial cavity, most cases in both groups showed normal appearance, thickness, color, and vasculature. However, in group A, thin EM and ab - normal vasculature were significantly higher than those in group B (27 [38.3%] vs. 1 [1.4%] and 25 [34.7%] vs. 4 [5.7%], respectively), as shown in Table 3. Preoperative TVS was consistent with OH comments on endometrial thickness in most cases in both groups. Fig. 1C shows a congested EM with obvious capillaries, while Fig. 1D shows dilated, tortuous, and worm-like capillaries prone to easy bleeding upon touch in the cases of AUB in group A. Access to DT to assess FT was successful in most cases in both groups. However, due to excessive bleeding, it was unsuccessful in a few patients (Table 4). FT function assessment revealed a significant reduction in peristalsis in the proximal part of the FT, in addition to a decreased bubble flow test in group A than in group B. Moreover, the combination of peristalsis and bubble flow tests (Darwishscope test) was significantly lower in the POCs group, especially for the right FT. Only 21 (30%) and 20 patients (29%) in both groups were satisfied with OH, respectively, but the rest were dissatisfied because of painful endometrial sampling using a Likert scale. The histopathological diagnosis was consistent with the hystero- scopic diagnosis in both groups.

Hormonal contraceptive use, including POCs, has incre- ased worldwide, accounting for almost 50% of contraceptive methods. 17 It is well-documented that POCs may induce a progressive reduction of endometrial thickness over the course of treatment, 18,19 as supported by the findings of this study of OH subjective assessment. A simple and easy practical technique was used to assess endometrial Table 4. Hysteroscopic evaluation of the Fallopian tubes in both groups Characteristic Study group (n=70) Control group (n=70) Chi-square P-value* Darwish hysteroscopic triad (FT) access Right tube 65 (92.8) 64 (91.4) 1.14 NS Left tube 65 (92.8) 66 (94.2) 1.90 NS Positive bubble flow test within 1 minute Right tube 28 (40.0) 45 (64.3) 8.27 0.004 Left tube 30 (42.9) 47 (67.1) 8.34 0.004 Positive bubble flow test within 2 minutes Right tube 29 (41.4) 48 (68.6) 10.40 0.001 Left tube 31 (44.3) 49 (70.0) 9.45 0.002 Total positive test Right tube 29 (41.4) 48 (68.6) 10.40 0.001 Left tube 31 (44.3) 49 (70.0) 9.45 0.002 Positive tubal peristalsis Right tube 16 (22.8) 35 (50.0) 11.10 <0.001 Left tube 21 (30.0) 33 (47.1) 3.65 0.056 Darwishscope test (combined bubble and peristalsis) Right tube 15 (21.4) 33 (47.1) 10.30 0.001 Left tube 17 (21.2) 29 (41.4) 3.92 0.048 Values are presented as frequency (%). FT: fallopian tube, NS: no significance. * P-value was significant if <0.05. Office hysteroscopy in progestin-only contraception 27 https://medsci.jejunu.ac.kr/ Atef Darwish, Ibrahim Mohammad, Samuel Gendy, Dina Darwish, Mohammad Ramdan thickness by applying gentle pressure along the entire posterior wall. These findings were consistent with the preoperative TVS and histopathological results in all cases. Additional advantages of OH over TVS include being the gold standard diagnostic tool for observing tiny lesions or abnormal vasculature and assessing FT function. OH provides a visual assessment of the EM vasculature. It was able to diagnose a normal endometrial vasculature pattern in 45 patients (64.3%) and a congested pattern in 25 POCs users (34.7%). Endometrial findings have been previously reported in greater detail, particularly in users of norplant implants, 20 but were solely based on endometrial sampling. A hysteroscopic diagnosis of a free endometrial cavity or any intrauterine lesion (supported by normal TVS) minimizes the burden on the pathologist by eliminating unnecessary samplings. 21 Moreover, it also alleviated invasive endometrial sampling pain, which was experienced by 49 (70%) and 50 patients (71%) in groups A and B, respectively. Furthermore, this also alleviated the anxiety and stress of waiting several days for biopsy results. In addition to the fact that these women are usually young and receiving progestins, OH plus TVS would eliminate unnecessary routine endometrial sampling. The collective advantages of OH include in vivo observation of the entire endometrial cavity, vessel morphology and distribution, and accurate information about non-vascular structures that may not be accessible by blind biopsies. 22 Practical methods to examine the different mechanisms of action of POCs include simple speculum examination to detect viscid cervical mucus, TVS, hormonal assays to diagnose inhibited ovulation and endometrial thickness, and invasive endometrial tissue sampling for histopathological examination. In modern practice, women require a simpler and less invasive method than painful endometrial curettage. In this study, the hysteroscopic assessment of endometrial thickness was consistent with preoperative TVS and histop- athology in all cases. Since both TVS and OH findings were consistent, we believe that they would be complementary in the quick assessment of endometrial abnormalities. Specific clinical characteristics of the patients should be considered, as previously recommended. 21 However, the advantages of OH over TVS include being the gold standard diagnostic tool for observing tiny lesions or abnormal vasculature and assessing FT function. Normal and thin EM were diagnosed in 36 (51.4%) and 27 cases (38.3%) using POCs, respectively. Moreover, en - dometrial polyps were easily diagnosed and treated in three cases (4.3%). In this study, a simple and practical method was used to assess endometrial thickness by applying gentle pressure along the entire posterior wall with the tip of the telescope to check for endometrial furrow formation. Simi - larly, OH offers a visual assessment of the EM vasculature. It was able to diagnose a normal endometrial vasculature pattern in 45 patients (64.3%) and a congested pattern in 25 POCs users (34.7%). A hysteroscopic diagnosis of a free endometrial cavity or any intrauterine lesion (supported by normal TVS) minimizes the burden on the pathologist by eliminating unnecessary samplings. 22 Moreover, it also alle- viated invasive endometrial sampling pain, which was expe- rienced by 49 (70%) and 50 patients (71%) in groups A and B, respectively. Furthermore, it alleviated the anxiety and stress of waiting several days for biopsy results. In addition to the fact that these women are usually young and receiv - ing progestins, OH plus TVS would eliminate unnecessary routine endometrial sampling. The collective advantages of OH include in vivo observation of the entire endometrial cavity, vessel morphology and distribution, and accurate information about nonvascular structures that may not be accessible by blind biopsies. 23 Regarding the effect of POCs on the FT, it is postulated that they may lead to a 40-50% reduction in the epithelial ciliary beat frequency and decreased contractions of the longitudinal muscular layer of the human FT compared with the baseline value. The former has been proven in an animal study 24 while the latter has been proven in an in vi- tro study. 25 In a pilot study, repeated hysterosalpingography (HSG) was used to confirm functional proximal FT occlu - sion in women using depot MPA. 26 Repeated HSG pain, irradiation, and invasiveness, in addition to ethical contro - versies, are the significant disadvantages of this study. For Vol. 21, No. 2, May 2024 28 https://medsci.jejunu.ac.kr/ Journal of Medicine and Life Science the past decade, our institution has been interested in study of the FT function utilizing hysteroscopy. 11-13,16 The unique advantage of using OH to assess FT in POCs users was ad - dressed in this study. This confirmed the postulated effect of POCs on the FT by statistically significant negative peri- stalsis and negative bubble flow tests in the proximal part of the FT, which are mostly attributed to the direct effect of progestins on the FT. In this study, negative bubble flow test

in POCs users indicated that the passage of bubbles to the FT is not a passive phenomenon but is controlled by the peristalsis of the proximal part of the FT. This observa - tion is supported by using the lowest intrauterine pressure sufficient for proper visualization and observing bubbles waiting for some time at the ostia, which contributed to reporting at 1 and 2 minutes (Table 4). Lastly, OH was diag- nosed as viscid cervical mucus in 26 of the 32 cases using POP. To the best of our knowledge, this is the first study to document the mechanisms of action of POCs utilizing OH, including the in vivo observation of the entire endometri - al cavity, endometrial thickness, vessel morphology and distribution, accurate assessment of FT function, and easy detection of viscid cervical mucus. An important issue was selecting a control group without hormonal treatment to avoid bias in interpreting the endometrial and FT changes with the use of POCs. Different forms of AUB with POCs contribute to the high incidence of discontinuation and subsequent undesired preg- nancy. In addition to systemic hormonal imbalances, local endometrial causes have been suggested. Despite well-doc- umented endometrial thinning in most cases at the EM level, there is a paradoxical increase in vascular defects that commonly cause occasional spotting. Bleeding with POCs may be attributed to fragile vessels due to a lack of stromal support, secondary to progestogen-induced endometrial dysfunction, which inhibits uterine vascular smooth muscle cell survival. 27 A human and animal study confirmed that endometrial thin-walled, hyperdilated, fragile microvessels were due to reduced proliferation of human and guinea pig endometrial vascular smooth muscle cells (VSMCs) in cases using long-acting POCs, as confirmed by altered transcrip - Figure 2. Management plan of abnormal uterine bleeding in POC regular users. AUB: abnormal uterine bleeding, POC: progestogen-only contra- ceptive, LNG: levonorgestrel, IUS: intrauterine system, COC: combined oral contraceptive, NSAID: nonsteroidal anti-inflammatory drug. Free endometrial cavity Free adnexae Suspected endometrial polyp 2D-TVS 3D-TVS No polypEndometrial polyp Office hysteroscopy Normal endometrial vasculature COCs Extraction Well-placed Displaced or Mal-rotated YesNO Hysteroscopic polypectomy Abnormal endometrial vasculature Sonohysterography Management plan of AUB in POC regular users Trans-vaginal ultrasonography (TVS) Tranexamic acid, diosmin, NSAID Systemic hormones: estrogen, COCs, norethindrone acetate 2 LNG-IUSOvarian cyst Office hysteroscopy in progestin-only contraception 29 https://medsci.jejunu.ac.kr/ Atef Darwish, Ibrahim Mohammad, Samuel Gendy, Dina Darwish, Mohammad Ramdan tion of some genes in the cultured endometrium. 28 Others have suggested using transvaginal color and pulsed Doppler ultrasonography as tools to detect increased blood perfusion in the uterine and spiral arteries, a significant decrease in RI and PI, and increased blood flow in the subendometri - al vessels. 29 Despite interesting Doppler studies, clinical decision-making cannot be based on these findings. More research is needed to gain a deeper understanding of the mechanisms and establish long-term interventions to man - age bleeding irregularities in POCs. 18 The use of OH in this study shortens this narrative. It properly assesses the endo - metrial thickness and vasculature and excludes any intra - uterine organic causes within a few minutes. Interestingly, it can diagnose a congested endometrium with easy bleeding, confirming a local vascular cause that may respond to vas - cular supportive therapy. In this study, normal endometrial thickness and vasculature diagnosed by OH were valuable negative findings, as they directed the gynecologist towards systemic causes such as improper or irregular use. In this study, hysteroscopic access to the cornual parts of the en - dometrial cavity was successful in more than 90% of the cases, despite AUB in many of them. This can be attributed to the use of a simple pump to wash blood clots from the en- dometrial cavity, as described in a previous study. 10 Despite the findings of this study being descriptive and based on OH, incorporating TVS and endometrial sampl- ing would provide additional insights into the mechanism. However, the heterogeneity of types, doses, duration, and routes of administration of POCs, the small sample size, including only symptomatic POCs users, the infreq- uent patient attendance for follow-up, and the lack of laparoscopic control of the impact of POCs on FT function due to ethical considerations were the main limitations. Moreover, this study lacks an assessment of the potential confounders of AUB. More studies on the endometrial pattern of individual types of POP are required, particularly after the introduction of the new generation of high-dose 4 mg drospirenone-only pills (DOP), which are administered for 24 days with 4 days off. 30 Additionally, hysteroscopic assessment of the endometrium is subjective, with possible intra-observer variations. Finally, the heterogeneity of group B is an additional limitation. This study calls for a univer- sally agreed-upon classification of normal and abnormal endometrial vasculature in POCs users and non-users to facilitate appropriate interventions. We invited interested hysteroscopists to share their research on normal and abnormal endometrial vasculature in different types of POCs, as observed by OH, such as dilated, tortuous, and worm-like capillaries (endometrial vascular dystrophy), believed to be caused by thrombosed capillaries. 31 The widespread use of OH in clinics, attending concise training courses, and increasing the orientation of gynecologists on technical skills would enhance their use in the field of contraception for the proper study of endometrial changes and help explain some related side effects. In conclusion, using OH as a simple diagnostic tool in cases of POCs would contribute to a better understanding of the mechani- sms of endometrial and FT effects and help explain some local endometrial causes of AUB. Furthermore, this assures that the combined TVS and OH restrict the need for routine invasive endometrial sampling for POCs users. In the era of precision medicine, the incorporation of OH into the diagnostic work-up algorithm for the management of AUB in regular POC users would help construct an individualized management plan, as shown in Fig. 2. ORCID Atef Darwish, https://orcid.org/0000-0003-0167-9337

1. Monterrosa-Castro A, Redondo-Mendoza V , Monterrosa-Blanco A. Current knowledge of progestin-only pills. Electron J Gen Med 2021;18:em320. 2. Ayalon NV , Segev L, Samson AO, Yagel S, Cohen SM, Green T, et al. Norethisterone reduces vaginal bleeding caused by progester- one-only birth control pills. J Clin Med 2022;11:3389. 3. Dilbaz B, Bülbül M, Dilbaz S, Yılmaz N, Sanisoğlu S. The efficacy, acceptability and continuation of postpartum, post-abortive pro- gestin-only pill: a pioneering prospective multicentric study from Turkey. J Turk Ger Gynecol Assoc 2022;23:255-62. Vol. 21, No. 2, May 2024 30 https://medsci.jejunu.ac.kr/ Journal of Medicine and Life Science 4. Fei YF, Smith YR, Dendrinos ML, Rosen MW, Quint EH. Consid- erations in adolescent use of the etonogestrel subdermal implant: a cohort study. Front Reprod Health 2021;3:780902. 5. Falase EA, Otolorin EO, Ladipo OA. Experience with the use of depo-medroxyprogesterone acetate in a Nigerian population. Afr J Med Med Sci 1988;17:209-13. 6. Romero SA, Young K, Hickey M, Su HI. Levonorgestrel intra- uterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev 2020;12:CD007245. 7. Shoupe D, Mishell DR Jr. Contraception. In: Goldman MB, Troisi R, Rexrode MK, editors. Women and health. 2nd ed. Cambridge (MA): Academic Press; 2013. pp.209-34. 8. Zigler RE, McNicholas C. Unscheduled vaginal bleeding with pro- gestin-only contraceptive use. Am J Obstet Gynecol 2017;216:443- 50. 9. Schrager S. Abnormal uterine bleeding associated with hormonal contraception. Am Fam Physician 2002;65:2073-80. 10. Darwish AM, Sayed EH, Mohammad SA, Mohammad II, Hassan HI. Reliability of out-patient hysteroscopy in one-stop clinic for ab- normal uterine bleeding. Gynecol Surg 2012;9:289-95. 11. Darwish AM, Hassanin AI, Aleem MAA, Mohammad II, Abousha- ma IH. Routine vaginoscopic office hysteroscopy in modern infertility work-up: a randomized controlled trial. Gynecol Surg 2014;11:185-9. 12. Darwish AM, Hassanin AI, Aleem MAA, Aboushama IH, Mo- hammad II. A novel use of vaginoscopic office hysteroscopy for prediction of tubal patency and peristalsis among infertile women: a preliminary study. Gynecol Surg 2016;13:187-92. 13. Darwish AMM, Darwish DA. Hysteroscopic Darwishscope test versus bubble flow patency test for normal and hydrosalpingeal fal- lopian tubes. J Gynecol Surg 2022;38:49-56. 14. Marikinti K. Hysteroscopic findings in women with a history of very thin endometrium during assisted conception treatments. Fertil Steril 2005;84:S364-5. 15. Garuti G, Cellani F, Garzia D, Colonnelli M, Luerti M. Accuracy of hysteroscopic diagnosis of endometrial hyperplasia: a retrospective study of 323 patients. J Minim Invasive Gynecol 2005;12:247-53. 16. Darwish AMM. Darwish hysteroscopic triad: a missed anatomic landmark. J Gynecol Surg 2021;37:94-5. 17. United Nations (UN). Contraceptive use by method 2019: data booklet [Internet]. Geneva: UN-iLibrary; c2019 [cited 2021 May 15]. Available from: https://doi.org/10.18356/1bd58a10-en. 18. Bastianelli C, Farris M, Bruni V , Rosato E, Brosens I, Benagiano G. Effects of progestin-only contraceptives on the endometrium. Ex- pert Rev Clin Pharmacol 2020;13:1103-23. 19. Dinh A, Sriprasert I, Williams AR, Archer DF. A review of the en- dometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women. Contraception 2015;91:360-7. 20. Jensen JT, Hanna C, Mishler E, Lim JY , Slayden OD. Effect of menstrual cycle phase and hormonal treatments on evaluation of tubal patency in baboons. J Med Primatol 2018;47:40-5. 21. Patrizi L, Ticconi C, Borelli B, Finocchiaro S, Chiaramonte C, Sesti F, et al. Clinical significance of endometrial abnormalities: an obser- vational study on 1020 women undergoing hysteroscopic surgery. BMC Womens Health 2022;22:106. 22. Pandey D, Kunamneni S, Inukollu PR, Su H. Establishing patterns on hysteroscopy in abnormal uterine bleeding (AUB). Gynecol Minim Invasive Ther 2017;6:178-82. 23. Hickey M, Fraser IS. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of break- through bleeding. Hum Reprod 2002;17:2428-34. 24. Li C, Zhang HY , Liang Y , Xia W, Zhu Q, Zhang D, et al. Effects of levonorgestrel and progesterone on oviductal physiology in mam- mals. Reprod Biol Endocrinol 2018;16:59. 25. Wånggren K, Stavreus-Evers A, Olsson C, Andersson E, Gem- zell-Danielsson K. Regulation of muscular contractions in the hu- man fallopian tube through prostaglandins and progestagens. Hum Reprod 2008;23:2359-68. 26. Jensen JT, Patil E, Seguin J, Thurmond A. Tubal patency during the menstrual cycle and during treatment with hormonal contraceptives: a pilot study in women. Acta Radiol 2017;58:1020-5. 27. Hickey M, Fraser I, Dwarte D, Graham S. Endometrial vasculature in norplant users: preliminary results from a hysteroscopic study. Hum Reprod 1996;11(Suppl 2):35-44. 28. Kayisli UA, Basar M, Guzeloglu-Kayisli O, Semerci N, Atkinson HC, Shapiro J, et al. Long-acting progestin-only contraceptives im- pair endometrial vasculature by inhibiting uterine vascular smooth muscle cell survival. Proc Natl Acad Sci U S A 2015;112:5153-8. 29. Essam M, Alhalabi A, Hamza H, Al-Sarag M. Role of transvaginal Doppler sonography in cases of irregular uterine bleeding with de- pot medroxyprogesterone acetate. Menoufia Med J 2019;32:1355-8. 30. Zuniga C, Forsberg H, Grindlay K. Experiences of progestin-only pill users in the United States and attitudes toward over-the-counter access. Perspect Sex Reprod Health 2023;55:104-12. 31. Eiran E. Hysteroscopy: endometrial vascular dystrophy: misnomer. Int J Reprod Contracept Obstet Gynecol 2022;11:636-8.